Tilray Stock Rises As Study Links Medical Cannabis To Lower Opioid Use
Tilray Brands Inc (NASDAQ:TLRY) shares are trading higher on Wednesday after a Marijuana Moment report cited findings from a new study showing medical cannabis legalization leads to significant reductions in opioid prescriptions. Here’s what investors need to know.
• TLRY is among today’s top performers. Stay ahead of the curve here.
What To Know: A study in the American Journal of Health Economics found medical cannabis legalization is “associated with significant reductions in opioid prescribing.”
Analyzing insurance claims for 15 to 20 million Americans annually from 2007-2020, researchers found that states with medical cannabis laws saw the rate of patients with opioid prescriptions fall by an average of 16%.
The study notes these reductions …